|
|
| Research article summary (published 20 Dec 2005): |
Effect of beta-blocker therapy on functional status in patients with heart failure--a meta-analysis.
Full Abstract
BACKGROUND: The results of randomised control trials (RCTs) evaluating the effect of beta-blockers on functional status in patients with chronic heart failure are conflicting. AIM: To perform a systematic review and meta-analysis of RCTs evaluating the effect of beta-blockers on New York Heart Association (NYHA) classification and exercise tolerance in chronic heart failure. METHODS AND RESULTS: We selected 28 RCTs evaluating beta-blocker versus placebo in addition to ACE inhibitor therapy. Combined results of 23 RCTs showed that beta-blockers improved NYHA class by at least one class with odds ratio (OR) 1.80 (1.33-2.43) p<0.0001. Meta-analysis of 10 RCTs showed a significant prolongation of exercise time by 44.19 (6.62-81.75) s p=0.021. Combining 8 RCTs evaluating the maximal peak oxygen uptake and 9 RCTs evaluating 6-min walk distance showed that beta-blockers had no significant effect compared with placebo, p=0.484, and p=0.730, respectively. Combined results of the 23 RCTs showed significant reducing effect on all cause mortality with OR=0.69 (0.59-0.82) p<0.0001. CONCLUSION: Chronic use of a beta-blocker in conjunction with ACE inhibitor therapy improves dyspnoea and prolongs exercise tolerance time, but has no significant effect on 6-min walk test or maximal oxygen uptake in patients with heart failure.
Author information
Author/s: Abdulla, Jawdat (J); Køber, Lars (L); Christensen, Erik (E); Torp-Pedersen, Christian (C);
Affiliation: Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark. ja(-atsign-)heart.dk
Journal and publication information
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
Journal: European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology (Eur J Heart Fail), published in Netherlands. (Language: eng)
Reference: 2006-Aug; vol 8 (issue 5) : pp 522-31
Dates: Created 2006/08/18; Completed 2006/12/12; Revised 2007/11/15;
PMID: 16376611, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Adrenergic beta-Antagonists (0)Related articles
These are the most related articles currently in our database:
- Beta-blockers, exercise, and ventilation in chronic heart failure.
30 May 2005 - Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failure.
30 May 1999 - Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure.
30 May 2005 - Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing.
30 Dec 2002 - [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance]
30 Dec 1997 - Surrogate end points in heart failure trials.
30 Jan 2003 - The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure.
30 Dec 2002 - Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
30 May 1993 - Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
30 Aug 2003 - Exercise testing with concurrent beta-blocker usage: is it useful? What do we learn?
30 May 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.